CHICAGO -- An investigational injectable that only requires dosing once every 4 weeks led to substantial weight loss in ...

There were 283,696 neonatal deaths from perinatal complications, with the top leading causes being disorders related to short ...

It also reflects a deeper problem in medicine and public health: the assumption that queer sex is inherently dangerous. This ...

Denosumab (Prolia) is a leading treatment for osteoporosis, but the rapid bone loss that can occur after discontinuing the ...

Two biomarker tests -- one for blood and the other for stool -- are mainstays in the treatment of inflammatory bowel disease ...

Note that some links may require registration or subscription. HHS announced an investigation into a major Michigan health ...

"It's not just taking something away, but really doing a careful assessment of how that medication works within that ...

CHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the ...

CHICAGO -- Adding investigational cagrilintide to a GLP-1 receptor agonist increased weight loss in adults with obesity with ...

Prior authorization varies by plan but often requires patients or their providers to get permission (also called ...

CHICAGO -- An investigational allogeneic stem cell-derived islet-cell therapy helped almost all patients with type 1 diabetes ...